RICHARD KELLERMAYER to Biological Products
This is a "connection" page, showing publications RICHARD KELLERMAYER has written about Biological Products.
Connection Strength
1.514
-
Failure Rate of Anti-Tumor Necrosis Factor a Biologics in Very Early Onset Inflammatory Bowel Disease. Inflamm Bowel Dis. 2024 03 01; 30(3):510-512.
Score: 0.796
-
Infliximab Can Be Effective in Pediatric Patients with Ulcerative Colitis and Primary Failure of Adalimumab. Ann Clin Lab Sci. 2022 Sep; 52(5):796-801.
Score: 0.718